Selected article for: "cascade activation and RLR cascade activation"

Author: Heaton, Steven M.; Borg, Natalie A.; Dixit, Vishva M.
Title: Ubiquitin in the activation and attenuation of innate antiviral immunity
  • Document date: 2016_1_11
  • ID: 42d77vxf_31
    Snippet: NOD2 features regularly in the immune signaling landscape, yet mechanisms of NOD2 regulation and cross-talk are only beginning to be revealed. Upon activation by MDP, NOD2 is ubiquitinated by TRIM27, leading to NOD2 degradation and NF-κB inhibition (Zurek et al., 2012) . NOD2 signaling is further suppressed by AIP4, which ubiquitinates Lys209 of receptor-interacting serine/threonine protein kinase 2 (RIPK2), the immediate downstream interacting .....
    Document: NOD2 features regularly in the immune signaling landscape, yet mechanisms of NOD2 regulation and cross-talk are only beginning to be revealed. Upon activation by MDP, NOD2 is ubiquitinated by TRIM27, leading to NOD2 degradation and NF-κB inhibition (Zurek et al., 2012) . NOD2 signaling is further suppressed by AIP4, which ubiquitinates Lys209 of receptor-interacting serine/threonine protein kinase 2 (RIPK2), the immediate downstream interacting partner of NOD2 (Fig. 2, right; Tao et al., 2009) . Conversely, NOD2-driven NF-κB activation is enhanced by LUB AC, a negative regulator of RLR signaling, as well as X-linked IAP (XIAP), which respectively ligate M1-and K63-linked polyubiquitin chains to NOD2 and RIPK2 (Damgaard et al., 2012) . These activating ubiquitin chains may be antagonized by the ubiquitin-editing enzyme A20 , which also disrupts ubiquitin-mediated TBK1 activation in the RLR signaling cascade as well as ubiquitin-mediated TRAF6 activation in the TLR cascade Parvatiyar et al., 2010) .

    Search related documents:
    Co phrase search for related documents
    • cross talk and negative regulator: 1
    • cross talk and NF κB activation: 1, 2, 3, 4, 5
    • cross talk and protein kinase: 1, 2, 3, 4, 5, 6, 7
    • cross talk and receptor interact: 1
    • cross talk and signal cascade: 1
    • cross talk and TBK1 activation: 1, 2
    • cross talk and ubiquitin chain: 1
    • immune signaling landscape and signaling landscape: 1, 2
    • interact partner and receptor interact: 1
    • MDP activation and NF κB activation: 1
    • negative regulator and NF κB activation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • negative regulator and protein kinase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • negative regulator and RLR negative regulator: 1, 2
    • negative regulator and serine threonine: 1
    • NF κB activation and protein kinase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • NF κB activation and serine threonine: 1, 2, 3
    • NF κB activation and TBK1 activation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • NF κB activation and ubiquitin chain: 1
    • polyubiquitin chain and ubiquitin chain: 1, 2, 3